Role of Survival Post-Progression in Phase III Trials of Systemic Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Systematic Review

por Hotta, Katsuyuki, Kiura, Katsuyuki, Fujiwara, Yoshiro, Takigawa, Nagio, Hisamoto, Akiko, Ichihara, Eiki, Tabata, Masahiro, Tanimoto, Mitsune
Publicado 2011

Docetaxel for non-small-cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation

por Yamane, Hiromichi, Ochi, Nobuaki, Yasugi, Masayuki, Tabayashi, Takayuki, Yamagishi, Tomoko, Monobe, Yasumasa, Hisamoto, Akiko, Kiura, Katsuyuki, Takigawa, Nagio
Publicado 2013

Treatment-Related Death in Patients with Small-Cell Lung Cancer in Phase III Trials over the Last Two Decades

por Ochi, Nobuaki, Hotta, Katsuyuki, Takigawa, Nagio, Oze, Isao, Fujiwara, Yoshiro, Ichihara, Eiki, Hisamoto, Akiko, Tabata, Masahiro, Tanimoto, Mitsune, Kiura, Katsuyuki
Publicado 2012